Suppr超能文献

早期监测活检中的巨噬细胞密度可预测未来肾移植功能。

Macrophage density in early surveillance biopsies predicts future renal transplant function.

机构信息

Institute of Pathology, Hannover Medical School, Hannover, Germany.

Division of Nephrology and Hypertension, Department of Internal Medicine, Hannover Medical School, Hannover, Germany.

出版信息

Kidney Int. 2017 Aug;92(2):479-489. doi: 10.1016/j.kint.2017.01.029. Epub 2017 Mar 27.

Abstract

Inflammation impairs renal allograft survival but is difficult to quantify by eye at low densities. Here we measured leukocyte abundance in early surveillance biopsies by digital image analysis to test for a role of chemokine receptor genotypes and analyze the predictive value of leukocyte subsets to allograft function. In six-week surveillance biopsies, T-cell (CD3), B-cell (CD20), macrophage (CD68), and dendritic cell (CD209) densities were assessed in whole slide scans. Renal cortical CD3, CD20, and CD68 were significantly higher in histologic rejection. The CCR2 V64I genotype was associated with lower CD3 and CD209 densities. Above-median CD68 density was significantly associated with lower combined patient and graft survival with a hazard ratio of 3.5 (95% confidence interval 1.1-11.0). Both CD20 and CD68 densities inversely correlated with estimated glomerular filtration rate (eGFR) four years after transplantation. Additionally, CD68 correlated with eGFR loss. Among histological measurements including a complete Banff classification, only CD68 density was a significant predictor of an eGFR under 30ml/min after four years (odds ratio 7.4, 1.8-31.0) and part of the best eGFR prediction set in a multivariable linear regression analysis of multiple clinical and pathologic parameters. In a second independent cohort, the original CD68 median maintained its discriminative power for survival and eGFR. Thus, digital high-resolution assessment of CD68 leukocyte infiltration significantly improves prognostic value of early renal transplant biopsies.

摘要

炎症会损害肾移植的存活,但在低密度时很难通过肉眼进行量化。在这里,我们通过数字图像分析测量早期监测活检中的白细胞丰度,以检验趋化因子受体基因型的作用,并分析白细胞亚群对移植物功能的预测价值。在 6 周的监测活检中,对整个幻灯片扫描中的 T 细胞(CD3)、B 细胞(CD20)、巨噬细胞(CD68)和树突状细胞(CD209)密度进行评估。组织学排斥中肾皮质 CD3、CD20 和 CD68 明显更高。CCR2 V64I 基因型与 CD3 和 CD209 密度降低相关。高于中位数的 CD68 密度与较低的患者和移植物联合存活率显著相关,风险比为 3.5(95%置信区间 1.1-11.0)。CD68 密度与四年后估计肾小球滤过率(eGFR)呈显著负相关。此外,CD68 与 eGFR 丢失相关。在包括完整 Banff 分类的组织学测量中,只有 CD68 密度是四年后 eGFR 低于 30ml/min 的显著预测因子(优势比 7.4,1.8-31.0),并且在多变量线性回归分析中,是多个临床和病理参数的最佳 eGFR 预测集的一部分。在第二个独立队列中,原始 CD68 中位数保持了其对生存和 eGFR 的区分能力。因此,数字高分辨率评估 CD68 白细胞浸润显著提高了早期肾移植活检的预后价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验